This was the stock's second consecutive day of losses.

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

The company is willing to back new limits on lucrative payments insurers can gain from diagnoses recorded by nurse ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

Humana Inc. closed 43.21% below its 52-week high of $406.46, which the company reached on July 18th.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

Humana said it is reaffirming its prior 2025 EPS guidance. The health insurer sees $14.68 in diluted EPS or $16.25 in ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $307.44, ...